ASGCT News   |   President's Message

President's Message—Abstracts, Value Summit, and ESGCT

Michele Calos, Ph.D. - October 09, 2018

The abstract collection is the lifeblood of ASGCT’s Annual Meeting, and the Society is excited to feature the future of our field at the Washington Hilton next year. I encourage all of you to consider submitting your research to the ASGCT Annual Meeting.

As the autumn leaves fall and a briskness enters the air, activities ramp up at ASGCT as we officially kick off Annual Meeting season. We’ve launched a new website, released our annual Exhibitor & Sponsor Prospectus, and both registration and housing at our host hotel open in the near future. Most importantly, however, the Society is set to open abstract submission for the 2019 Annual Meeting on Wednesday, October 17—less than one week from today!

All publishing and submission guidelines are in the Call for Abstracts.

This collection of field-leading research is the lifeblood of ASGCT’s meeting, and the Society is excited to feature the future of our field at the Washington Hilton next year. I encourage all of you to consider submitting your research to the ASGCT Annual Meeting.

In an effort to grow ASGCT’s influence even further beyond the Annual Meeting, the Society hosted our first-ever policy summit, ASGCT Value Summit: Advancing Patient Access to the Benefits of Gene Therapy, in Washington, D.C. on September 24. Through a full day of sessions, stakeholders with various interests united by their commitment to advancing gene and cell therapy discussed strategies for maximizing patient access to durable, potentially curative treatments while maintaining the level of innovation that made them possible.

Many of the presenters from the ASGCT Value Summit have agreed to let ASGCT post their presentation materials online for those who were unable to attend the summit. I would like to thank those who shared their knowledge, both in-person and those who have made their expertise available online.

VIEW VALUE SUMMIT PRESENTATIONS

Finally, I invite all of our members to seek out the ASGCT booth at the European Society of Gene & Cell Therapy’s upcoming Annual Congress, October 16-19, in Lausanne, Switzerland. We look forward to this opportunity to connect with many of our members outside of our own meeting every year and look forward to seeing you in Switzerland!

Related Articles

ASGCT News

Dr. Terence Flotte Calls for CGT Investment and Collaboration During Congressional Testimony

Read Dr. Flotte's testimony + watch the hearing - February 29, 2024
ASGCT News

Mohamed Abou-el-Enein Appointed Editor of Molecular Therapy Methods and Clinical Development

Dr. Abou-el-Enein began five-year term Jan. 1. - January 04, 2024
ASGCT News

For Members, ASGCT Has More Programming, Research Funding, and Opportunities Than Ever

Join the largest CGT community - October 03, 2023
ASGCT News

Drew Weissman & Katalin Karikó to Co-Receive 2023 Nobel Prize for Discoveries in mRNA Technology

October 02, 2023